Literature DB >> 32146647

In Situ Regulated Dopamine Transporter Trafficking: There's No Place Like Home.

Rita R Fagan1, Patrick J Kearney1, Haley E Melikian2.   

Abstract

Dopamine (DA) is critical for motivation, reward, movement initiation, and learning. Mechanisms that control DA signaling have a profound impact on these important behaviors, and additionally play a role in DA-related neuropathologies. The presynaptic SLC6 DA transporter (DAT) limits extracellular DA levels by clearing released DA, and is potently inhibited by addictive and therapeutic psychostimulants. Decades of evidence support that the DAT is subject to acute regulation by a number of signaling pathways, and that endocytic trafficking strongly regulates DAT availability and function. DAT trafficking studies have been performed in a variety of model systems, including both in vitro and ex vivo preparations. In this review, we focus on the breadth of DAT trafficking studies, with specific attention to, and comparison of, how context may influence DAT's response to different stimuli. In particular, this overview highlights that stimulated DAT trafficking not only differs between in vitro and ex vivo environments, but also is influenced by both sex and anatomical subregions.

Entities:  

Keywords:  Dopamine transporter; Membrane trafficking; Striatum

Mesh:

Substances:

Year:  2020        PMID: 32146647      PMCID: PMC7261626          DOI: 10.1007/s11064-020-03001-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  86 in total

1.  A possible role for tyrosine kinases in the regulation of the neuronal dopamine transporter in mouse striatum.

Authors:  J R Simon; D J Bare; B Ghetti; J A Richter
Journal:  Neurosci Lett       Date:  1997-03-21       Impact factor: 3.046

2.  Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter.

Authors:  Rong Chen; Michael R Tilley; Hua Wei; Fuwen Zhou; Fu-Ming Zhou; San Ching; Ning Quan; Robert L Stephens; Erik R Hill; Timothy Nottoli; Dawn D Han; Howard H Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

3.  Regional Heterogeneity of D2-Receptor Signaling in the Dorsal Striatum and Nucleus Accumbens.

Authors:  Pamela F Marcott; Sheng Gong; Prashant Donthamsetti; Steven G Grinnell; Melissa N Nelson; Amy H Newman; Lutz Birnbaumer; Kirill A Martemyanov; Jonathan A Javitch; Christopher P Ford
Journal:  Neuron       Date:  2018-04-12       Impact factor: 17.173

4.  Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters.

Authors:  G M Daniels; S G Amara
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

5.  Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism.

Authors:  Tatiana Sorkina; Brian R Hoover; Nancy R Zahniser; Alexander Sorkin
Journal:  Traffic       Date:  2005-02       Impact factor: 6.215

6.  Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.

Authors:  Z B Pristupa; F McConkey; F Liu; H Y Man; F J Lee; Y T Wang; H B Niznik
Journal:  Synapse       Date:  1998-09       Impact factor: 2.562

7.  Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.

Authors:  Freja H Hansen; Tina Skjørringe; Saiqa Yasmeen; Natascha V Arends; Michelle A Sahai; Kevin Erreger; Thorvald F Andreassen; Marion Holy; Peter J Hamilton; Viruna Neergheen; Merete Karlsborg; Amy H Newman; Simon Pope; Simon J R Heales; Lars Friberg; Ian Law; Lars H Pinborg; Harald H Sitte; Claus Loland; Lei Shi; Harel Weinstein; Aurelio Galli; Lena E Hjermind; Lisbeth B Møller; Ulrik Gether
Journal:  J Clin Invest       Date:  2014-06-09       Impact factor: 14.808

8.  Chemical labelling for visualizing native AMPA receptors in live neurons.

Authors:  Sho Wakayama; Shigeki Kiyonaka; Itaru Arai; Wataru Kakegawa; Shinji Matsuda; Keiji Ibata; Yuri L Nemoto; Akihiro Kusumi; Michisuke Yuzaki; Itaru Hamachi
Journal:  Nat Commun       Date:  2017-04-07       Impact factor: 14.919

9.  Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine.

Authors:  Jason M Williams; W Anthony Owens; Gregory H Turner; Christine Saunders; Concetta Dipace; Randy D Blakely; Charles P France; John C Gore; Lynette C Daws; Malcolm J Avison; Aurelio Galli
Journal:  PLoS Biol       Date:  2007-10-16       Impact factor: 8.029

10.  Super-resolution microscopy reveals functional organization of dopamine transporters into cholesterol and neuronal activity-dependent nanodomains.

Authors:  Troels Rahbek-Clemmensen; Matthew D Lycas; Simon Erlendsson; Jacob Eriksen; Mia Apuschkin; Frederik Vilhardt; Trine N Jørgensen; Freja H Hansen; Ulrik Gether
Journal:  Nat Commun       Date:  2017-09-29       Impact factor: 14.919

View more
  6 in total

1.  Chemogenetic Manipulation of Dopamine Neurons Dictates Cocaine Potency at Distal Dopamine Transporters.

Authors:  Zachary D Brodnik; Wei Xu; Aashita Batra; Stacia I Lewandowski; Christina M Ruiz; Ole V Mortensen; Sandhya Kortagere; Stephen V Mahler; Rodrigo A España
Journal:  J Neurosci       Date:  2020-10-12       Impact factor: 6.167

Review 2.  Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity.

Authors:  Douglas R Miller; Mengfei Bu; Adithya Gopinath; Luis R Martinez; Habibeh Khoshbouei
Journal:  J Pharmacol Exp Ther       Date:  2021-09-17       Impact factor: 4.402

3.  Dopaminergic Ric GTPase activity impacts amphetamine sensitivity and sleep quality in a dopamine transporter-dependent manner in Drosophila melanogaster.

Authors:  Rita R Fagan; Patrick J Kearney; Dino Luethi; Nicholas C Bolden; Harald H Sitte; Patrick Emery; Haley E Melikian
Journal:  Mol Psychiatry       Date:  2021-09-01       Impact factor: 13.437

Review 4.  Dynamic control of the dopamine transporter in neurotransmission and homeostasis.

Authors:  Mengfei Bu; Matthew J Farrer; Habibeh Khoshbouei
Journal:  NPJ Parkinsons Dis       Date:  2021-03-05

Review 5.  Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction.

Authors:  Francesca Chiara Pignalosa; Antonella Desiderio; Paola Mirra; Cecilia Nigro; Giuseppe Perruolo; Luca Ulianich; Pietro Formisano; Francesco Beguinot; Claudia Miele; Raffaele Napoli; Francesca Fiory
Journal:  Int J Mol Sci       Date:  2021-11-16       Impact factor: 5.923

6.  Identification by proximity labeling of novel lipidic and proteinaceous potential partners of the dopamine transporter.

Authors:  Dolores Piniella; Elena Martínez-Blanco; David Bartolomé-Martín; Ana B Sanz-Martos; Francisco Zafra
Journal:  Cell Mol Life Sci       Date:  2021-10-28       Impact factor: 9.261

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.